Endogenous estrogen deficiency and the development of chronic musculoskeletal pain : A review
Sexual dimorphism of chronic diseases is a phenomenon determined by differences in the hormonal status of men and women. In this regard, estrogens, which have a complex effect on the body, are of great interest. In particular, estrogens play an important role in the natural control of pain and inflammation. A decrease in estrogen levels associated with menopause or iatrogenic effects (hysterectomy, use of aromotase inhibitors), as well as mutations of genes responsible for the synthesis of structural components of membrane estrogen receptors (ESR1 and ESR2), can significantly reduce the positive effects of these hormones. Deficiency of estrogen can become one of the reasons for the development of serious pathological changes in particular, the formation of chronic pain associated with the pathology of the musculoskeletal system.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
Terapevticheskii arkhiv - 94(2022), 5 vom: 17. Juni, Seite 683-688 |
Sprache: |
Russisch |
---|
Beteiligte Personen: |
Panevin, T S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chronic pain |
---|
Anmerkungen: |
Date Completed 28.10.2022 Date Revised 28.10.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.26442/00403660.2022.05.201490 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348014759 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348014759 | ||
003 | DE-627 | ||
005 | 20231226035209.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||rus c | ||
024 | 7 | |a 10.26442/00403660.2022.05.201490 |2 doi | |
028 | 5 | 2 | |a pubmed24n1160.xml |
035 | |a (DE-627)NLM348014759 | ||
035 | |a (NLM)36286969 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 1 | |a Panevin, T S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endogenous estrogen deficiency and the development of chronic musculoskeletal pain |b A review |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.10.2022 | ||
500 | |a Date Revised 28.10.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Sexual dimorphism of chronic diseases is a phenomenon determined by differences in the hormonal status of men and women. In this regard, estrogens, which have a complex effect on the body, are of great interest. In particular, estrogens play an important role in the natural control of pain and inflammation. A decrease in estrogen levels associated with menopause or iatrogenic effects (hysterectomy, use of aromotase inhibitors), as well as mutations of genes responsible for the synthesis of structural components of membrane estrogen receptors (ESR1 and ESR2), can significantly reduce the positive effects of these hormones. Deficiency of estrogen can become one of the reasons for the development of serious pathological changes in particular, the formation of chronic pain associated with the pathology of the musculoskeletal system | ||
650 | 4 | |a Review | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a chronic pain | |
650 | 4 | |a estrogen receptors | |
650 | 4 | |a estrogens | |
650 | 4 | |a fibromyalgia | |
650 | 4 | |a rheumatoid arthritis | |
650 | 7 | |a Receptors, Estrogen |2 NLM | |
650 | 7 | |a Estrogens |2 NLM | |
700 | 1 | |a Bobkova, A O |e verfasserin |4 aut | |
700 | 1 | |a Karateev, A E |e verfasserin |4 aut | |
700 | 1 | |a Zotkin, E G |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Terapevticheskii arkhiv |d 1949 |g 94(2022), 5 vom: 17. Juni, Seite 683-688 |w (DE-627)NLM000055425 |x 0040-3660 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2022 |g number:5 |g day:17 |g month:06 |g pages:683-688 |
856 | 4 | 0 | |u http://dx.doi.org/10.26442/00403660.2022.05.201490 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 94 |j 2022 |e 5 |b 17 |c 06 |h 683-688 |